Bristol Myers Squibb · 1 day ago
Sr. Director, U.S Policy - Medicare Part B & Reimbursement Strategy
Princeton - NJ - US
Full-time
Hybrid
Director/Executive
$246K/yr - $298K/yr
12+ years expBristol Myers Squibb is a company dedicated to transforming patients' lives through science. The Senior Director will partner with the Executive Director, Policy and Research to shape and drive strategy related to Medicare Part A and Part B coverage and reimbursement, while representing BMS in external engagements with trade associations and government officials.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Drive policy strategies to protect innovation and patient access under Medicare Part A and Part B
Collaborate with internal teams (legal, government affairs, market access) to align advocacy efforts
Lead cross-functional workgroups to develop proactive solutions for pricing and reimbursement challenges
Develop forward looking strategies to ensure optimal coverage and reimbursement of BMS products in government programs
Advise business partners on appropriate policy and advocacy approaches to resolve access issues
Collaborate with business partners to anticipate Medicare coverage and reimbursement needs and develop strategies to ensure timely submission of Medicare coding and reimbursement requirements e.g., J-code submissions, ICD-10 coding, NTAPs, etc
Represent the organization in industry coalitions, trade associations, and stakeholder forums
Build and maintain relationships with policymakers, regulators, and advocacy groups
Prepare and deliver testimony, comments, and briefing materials for legislative and regulatory processes
Qualification
Required
Advanced degree in Public Policy, Health Economics, Law, or related field
12+ years of experience in health policy, government affairs, or reimbursement strategy, with a focus on physician-administered medicines
Strong understanding of CMS regulations, coding, and payment methodologies and physician reimbursement dynamics
Experience in the biotechnology/pharmaceutical industry is required
Demonstrated ability to build consensus and drive alignment across complex organizational structures
Strong business acumen, strategic mindset, and executive presence
Excellent analytical, communication, and interpersonal skills
Ability to collaborate effectively with internal and external stakeholders in a fast-paced, collegial environment
Domestic travel required (up to 20%)
Preferred
People management experience preferred
Benefits
Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Charles Bancroft
CFO
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
Recent News
The Motley Fool
2026-01-24
Pharma Letter
2026-01-24
Company data provided by crunchbase